Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy

NCT00099632 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

484

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Emtricitabine/Tenofovir Disoproxil Fumarate
DRUG: Lamivudine/Zidovudine
DRUG: Lopinavir/Ritonavir
DRUG: single dose Nevirapine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)